Pancreatic Cancer Research

ResearcherShanghaiTech UniversityActive in the last 2 years

Hongli Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9002-2603; OpenAlex author ID A5100605061. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

  1. Triptolide-based cleavable antibody-drug conjugates for pancreatic cancer. Last author DOI 10.1016/j.ejmech.2025.117798↗
  2. Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phas… Co-author DOI 10.1371/journal.pone.0294564↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huihui Wang · 1 shared paper, 2025 · strength 0.27
  2. Ken Herrmann · 1 shared paper, 2023 · strength 0.16
  3. Aashna Karbhari · 1 shared paper, 2023 · strength 0.16
  4. Diane M. Simeone · 1 shared paper, 2023 · strength 0.16
  5. Mark Joseph Truty · 1 shared paper, 2023 · strength 0.16
  6. Ajit Harishkumar Goenka · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.